Frisch Financial Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$261K	Buy	+5,359	New	+$261K	0.06%	120
2021 Q3	–	Sell	-1,250	Closed	-$202K	–	151
2021 Q2	$202K	Buy	+1,250	New	+$202K	0.06%	148